SMN1 and proximal spinal muscular atrophy: Although the absence of both copies of the SMN1 gene is reported to be a very reliable assay for the molecular diagnosis of SMA, approximately 4% of SMA patients have other types of mutations that will not be detected by homozygous deletion testing [16].